Pemetrexed [clinicaltrials_resource:NCT00190983/group/O1]
Pemetrexed: 900 mg/m2 (700 mg/m2 for patients with prior radiotherapy) intravenous (IV) over 10 minutes every 21 days until disease progression
group [clinicaltrials_vocabulary:group]
NCT00190983 measurement [clinicaltrials_resource:NCT00190983/measurement/0189be17c3bc5c0b59e44ee7ef8b4546]NCT00190983 measurement [clinicaltrials_resource:NCT00190983/measurement/2d4c50970cb2e68399704524b3cb2870]NCT00190983 measurement [clinicaltrials_resource:NCT00190983/measurement/86866bf5340df68a089e1d1099091653]NCT00190983 measurement [clinicaltrials_resource:NCT00190983/measurement/9e49ea8c4c7216839fd12640c4201bdd]NCT00190983 measurement [clinicaltrials_resource:NCT00190983/measurement/b600dcd2f94a8b2254a4e76c26ca104a]NCT00190983 measurement [clinicaltrials_resource:NCT00190983/measurement/bbb5f0d9d375aac30712a8bcb2c2e64c]NCT00190983 measurement [clinicaltrials_resource:NCT00190983/measurement/bcb8fd015b38778c8eaf55f0cf9b716e]NCT00190983 measurement [clinicaltrials_resource:NCT00190983/measurement/c3856cebd2c84bc4804d9c27a9b27d7b]
group id [clinicaltrials_vocabulary:group-id]
Pemetrexed [clinicaltrials_resource:NCT00190983/group/O1]
Pemetrexed: 900 mg/m2 (700 mg/m2 for patients with prior radiotherapy) intravenous (IV) over 10 minutes every 21 days until disease progression
Bio2RDF identifier
NCT00190983/group/O1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT00190983/group/O1
group id [clinicaltrials_vocabulary:group-id]
description
Pemetrexed: 900 mg/m2 (700 mg/ ...... days until disease progression
@en
identifier
clinicaltrials_resource:NCT00190983/group/O1
title
Pemetrexed
@en
type
label
Pemetrexed [clinicaltrials_resource:NCT00190983/group/O1]
@en